Literature DB >> 2123494

Sphingolipid metabolism in organotypic mouse keratinocyte cultures.

K C Madison1, D C Swartzendruber, P W Wertz, D T Downing.   

Abstract

Ceramides are the dominant component of the stratum corneum intercellular lipid lamellae, which constitute the epidermal permeability barrier. Only pig and human epidermal ceramides have been extensively characterized and the structures of the ceramides of cultured keratinocytes have not been previously investigated. In the present studies, we have characterized the ceramides synthesized by organotypic lifted mouse keratinocyte cultures for the first time and compared them to the ceramides of intact mouse epidermis. Both mouse epidermis and cultures contained five ceramides, ceramide 1 being the least polar and ceramide 5 the most polar. Ceramide 1 was a group of acylceramides, i.e., very-long-chain omega-hydroxyceramides with an ester-linked nonhydroxy fatty acid. Ceramide 2 contained medium-length saturated nonhydroxy fatty acids. (In culture, the ceramide 2 band was split into two parts with the slightly more polar ceramide 2' containing short-chain saturated nonhydroxy fatty acids.) Ceramide 5 contained short-chain alpha-hydroxy fatty acids. The structures of ceramides 1, 2, and 5 were analagous to those of pig and human epidermis. Mouse epidermal ceramide 3 was quite unusual, containing beta-hydroxy fatty acids, a structure not previously identified among mammalian ceramides. In contrast, culture ceramide 3 was composed of omega-hydroxy fatty acids with a chain-length distribution similar to that of ceramide 1. Mouse ceramide 4 was composed of fatty acids with chromatographic mobility similar to hydroxy fatty acids but with different chemical reactivity; it remains only partially characterized. Culture ceramide 4 was present in quantities too small for analysis. All ceramides in mouse epidermis and cultures contained only sphingosine bases, whereas pig and human ceramides also contain phytosphingosine. These results indicate that considerable diversity of ceramide structures occurs among mammalian species and that cultured keratinocytes may only partially reproduce the in vivo complement of ceramides. Using labeled serine in keratinocyte cultures, we have also demonstrated the de novo synthesis of ceramides and the transfer of label from glucosylceramides to ceramides during terminal differentiation of lifted cultures. The covalently bound corneocyte lipid envelope, which has recently been characterized in pig and human epidermis, was also present in mouse epidermis and was reproduced by the lifted cultures. Very-long-chain omega-hydroxyceramides were the dominant bound lipid and labeling studies in culture indicated that they were derived from ceramides synthesized in the viable epidermis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123494     DOI: 10.1111/1523-1747.ep12514333

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  Isolation of a mesenchymal cell population from murine dermis that contains progenitors of multiple cell lineages.

Authors:  Lauren Crigler; Amita Kazhanie; Tae-Jin Yoon; Julia Zakhari; Joanna Anders; Barbara Taylor; Victoria M Virador
Journal:  FASEB J       Date:  2007-03-23       Impact factor: 5.191

2.  Bacterial immunogenic α-galactosylceramide identified in the murine large intestine: dependency on diet and inflammation.

Authors:  Johanna von Gerichten; Dominic Lamprecht; Lukáš Opálka; Daphnée Soulard; Christian Marsching; Robert Pilz; Valentin Sencio; Silke Herzer; Bruno Galy; Viola Nordström; Carsten Hopf; Hermann-Josef Gröne; François Trottein; Roger Sandhoff
Journal:  J Lipid Res       Date:  2019-09-04       Impact factor: 5.922

3.  Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier.

Authors:  J M Jensen; S Schütze; M Förl; M Krönke; E Proksch
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

4.  Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria?

Authors:  Clara Bionda; Jacques Portoukalian; Daniel Schmitt; Claire Rodriguez-Lafrasse; Dominique Ardail
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

5.  Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4.

Authors:  Anne McMahon; Igor A Butovich; Nathan L Mata; Martin Klein; Robert Ritter; James Richardson; David G Birch; Albert O Edwards; Wojciech Kedzierski
Journal:  Mol Vis       Date:  2007-02-26       Impact factor: 2.367

6.  Defects in Stratum Corneum Desquamation Are the Predominant Effect of Impaired ABCA12 Function in a Novel Mouse Model of Harlequin Ichthyosis.

Authors:  Lei Zhang; Michael Ferreyros; Weiguo Feng; Melanie Hupe; Debra A Crumrine; Jiang Chen; Peter M Elias; Walter M Holleran; Lee Niswander; Daniel Hohl; Trevor Williams; Enrique C Torchia; Dennis R Roop
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

7.  Comprehensive identification of sphingolipid species by in silico retention time and tandem mass spectral library.

Authors:  Hiroshi Tsugawa; Kazutaka Ikeda; Wataru Tanaka; Yuya Senoo; Makoto Arita; Masanori Arita
Journal:  J Cheminform       Date:  2017-03-15       Impact factor: 5.514

8.  Fatty acid transport protein 4 is required for incorporation of saturated ultralong-chain fatty acids into epidermal ceramides and monoacylglycerols.

Authors:  Meei-Hua Lin; Fong-Fu Hsu; Debra Crumrine; Jason Meyer; Peter M Elias; Jeffrey H Miner
Journal:  Sci Rep       Date:  2019-09-13       Impact factor: 4.379

9.  Metabolomics Study of Resina Draconis on Myocardial Ischemia Rats Using Ultraperformance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry Combined with Pattern Recognition Methods and Metabolic Pathway Analysis.

Authors:  Yunpeng Qi; Haiwei Gu; Yunlong Song; Xin Dong; Aijun Liu; Ziyang Lou; Guorong Fan; Yifeng Chai
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-26       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.